SCHEMBL9951913

SCHEMBL9951913

Cc1cccc(C)c1OCC(=O)[C@@H](C(N)c1ccccc1)[C@@H](O)C[C@H](NC(=O)C(C(C)C)N1CCCNC1=O)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC3 O15438 1/20 0.61
ABCC4 O15439 1/20 0.61
ABCB11 O95342 1/20 0.61
PGR P06401 1/20 0.61
ABCB1 P08183 1/20 0.61
CYP3A4 P08684 1/20 0.61
ADORA3 P0DMS8 1/20 0.61
CHRM1 P11229 1/20 0.61
TBXA2R P21731 1/20 0.61
ADRA1A P35348 1/20 0.61
OPRM1 P35372 1/20 0.61
HTR2B P41595 1/20 0.61
KCNH2 Q12809 1/20 0.61
SCN5A Q14524 1/20 0.61
ABCG2 Q9UNQ0 1/20 0.61
GHSR Q92847 1/20 0.30
EIF2S1 P05198 1/20 0.30
EIF2AK3 Q9NZJ5 1/20 0.30
KMT2A Q03164 1/20 0.30
SCN4A P35499 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL673797 0.90 CYP3A4 (0.75) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7987508 0.90 CYP3A4 (0.75) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7977464 0.81 CYP3A4 (0.62) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL2059564 0.81 CYP3A4 (0.62) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7988988 0.80 CYP3A4 (0.61) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL2059543 0.80 CYP3A4 (0.61) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7994627 0.80 CYP3A4 (0.60) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7988693 0.78 CYP3A4 (0.58) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL7987596 0.77 CYP3A4 (0.57) ABCC3ABCC4ABCB11PGRABCB1
SCHEMBL2059385 0.77 KLK5 (0.39) ABCC3ABCC4ABCB11PGRABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2654791-A1 METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING HIV PROTEASE INHIBITORS The Feinstein Institute for Medical Research (US) 2013-10-30 EP disclosed
WO-2012088305-A1 METHODS FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING HIV PROTEASE INHIBITORS THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH (US) 2012-06-28 WO disclosed